000			01605 a2200433 4500
005			20250516184243.0
264		0	_c20140317
008			201403s 0 0 eng d
022			_a1097-6787
024	7		_a10.1016/j.jaad.2013.09.044 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeslie, Kieron S
245	0	0	_aAn open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa. _h[electronic resource]
260			_bJournal of the American Academy of Dermatology _cFeb 2014
300			_a243-51 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHidradenitis Suppurativa _xdiagnosis
650	0	4	_aHumans
650	0	4	_aInjections, Subcutaneous
650	0	4	_aInterleukin 1 Receptor Antagonist Protein _xadministration & dosage
650	0	4	_aMale
650	0	4	_aPatient Satisfaction _xstatistics & numerical data
650	0	4	_aPilot Projects
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aTripathi, Shivani V
700	1		_aNguyen, Tien V
700	1		_aPauli, Mariela
700	1		_aRosenblum, Michael D
773	0		_tJournal of the American Academy of Dermatology _gvol. 70 _gno. 2 _gp. 243-51
856	4	0	_uhttps://doi.org/10.1016/j.jaad.2013.09.044 _zAvailable from publisher's website
999			_c23345055 _d23345055